Accelerated Approval Withdrawals: Will Non-Oncology Indications Stop ‘Dangling’ In 2024?
Executive Summary
While at least 25 accelerated approval cancer indications or drugs have been pulled or requested withdrawn since 2020, there has not yet been a similar concerted regulatory effort in the non-oncology space despite a large number of products with overdue postmarketing requirements.